Synowitz M - Search Results

1

Correction: CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.

Drachsler M, Kleber S, Mateos A, Volk K, Mohr N, Chen S, Cirovic B, Tüttenberg J, Gieffers C, Sykora J, Wirtz C, Mueller W, Synowitz M, Martin-Villalba A. Drachsler M, et al. Among authors: synowitz m. Cell Death Dis. 2020 Jul 22;11(7):558. doi: 10.1038/s41419-020-2698-3. Cell Death Dis. 2020. PMID: 32699236 Free PMC article.

2

CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.

Drachsler M, Kleber S, Mateos A, Volk K, Mohr N, Chen S, Cirovic B, Tüttenberg J, Gieffers C, Sykora J, Wirtz CR, Mueller W, Synowitz M, Martin-Villalba A. Drachsler M, et al. Among authors: synowitz m. Cell Death Dis. 2016 Apr 28;7(4):e2209. doi: 10.1038/cddis.2016.102. Cell Death Dis. 2016. PMID: 27124583 Free PMC article.

3

Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma.

Mastrella G, Hou M, Li M, Stoecklein VM, Zdouc N, Volmar MNM, Miletic H, Reinhard S, Herold-Mende CC, Kleber S, Eisenhut K, Gargiulo G, Synowitz M, Vescovi AL, Harter PN, Penninger JM, Wagner E, Mittelbronn M, Bjerkvig R, Hambardzumyan D, Schüller U, Tonn JC, Radke J, Glass R, Kälin RE. Mastrella G, et al. Among authors: synowitz m. Cancer Res. 2019 May 1;79(9):2298-2313. doi: 10.1158/0008-5472.CAN-18-0881. Epub 2019 Feb 4. Cancer Res. 2019. PMID: 30718358 Free article.

4

To treat or not to treat? A retrospective multicenter assessment of survival in patients with IDH-mutant low-grade glioma based on adjuvant treatment.

Paľa A, Coburger J, Scherer M, Ahmeti H, Roder C, Gessler F, Jungk C, Scheuerle A, Senft C, Tatagiba M, Synowitz M, Wirtz CR, Schmitz B, Unterberg AW. Paľa A, et al. Among authors: synowitz m. J Neurosurg. 2019 Jul 19;133(2):273-280. doi: 10.3171/2019.4.JNS183395. Print 2020 Aug 1. J Neurosurg. 2019. PMID: 31323633

5

Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging.

Scherer M, Ahmeti H, Roder C, Gessler F, Jungk C, Pala A, Mayer B, Senft C, Tatagiba M, Synowitz M, Wirtz CR, Unterberg AW, Coburger J. Scherer M, et al. Among authors: synowitz m. Neurosurgery. 2020 Jan 1;86(1):E64-E74. doi: 10.1093/neuros/nyz397. Neurosurgery. 2020. PMID: 31574147

6

Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche.

Caylioglu D, Meyer RJ, Hellmold D, Kubelt C, Synowitz M, Held-Feindt J. Caylioglu D, et al. Among authors: synowitz m. Int J Mol Sci. 2021 Mar 30;22(7):3606. doi: 10.3390/ijms22073606. Int J Mol Sci. 2021. PMID: 33808494 Free PMC article.

7

Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment.

Adamski V, Hempelmann A, Flüh C, Lucius R, Synowitz M, Hattermann K, Held-Feindt J. Adamski V, et al. Among authors: synowitz m. Oncotarget. 2017 Nov 18;8(64):108064-108078. doi: 10.18632/oncotarget.22514. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296224 Free PMC article.

8

Microglia/macrophage-derived human CCL18 promotes glioma progression via CCR8-ACP5 axis analyzed in humanized slice model.

Huang Y, Motta E, Nanvuma C, Kuhrt LD, Yuan Y, Xia P, Lubas M, Zhu S, Schnauss M, Qazi N, Hu F, Zhang H, Lei T, Synowitz M, Flüh C, Kettenmann H. Huang Y, et al. Among authors: synowitz m. Cell Rep. 2022 Apr 12;39(2):110670. doi: 10.1016/j.celrep.2022.110670. Cell Rep. 2022. PMID: 35417708 Free article.

9

Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma.

Kubelt C, Hellmold D, Esser D, Ahmeti H, Synowitz M, Held-Feindt J. Kubelt C, et al. Among authors: synowitz m. Cells. 2023 May 27;12(11):1491. doi: 10.3390/cells12111491. Cells. 2023. PMID: 37296610 Free PMC article.

10

Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.

Floyd DH, Zhang Y, Dey BK, Kefas B, Breit H, Marks K, Dutta A, Herold-Mende C, Synowitz M, Glass R, Abounader R, Purow BW. Floyd DH, et al. Among authors: synowitz m. PLoS One. 2014 May 7;9(5):e96239. doi: 10.1371/journal.pone.0096239. eCollection 2014. PLoS One. 2014. PMID: 24805821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters